Webinar: The Basics of Moving Your CNS Therapeutic from Lab to Patient
Presented by Charles River Laboratories and NeuroSphere
The phases of drug development can be complex to navigate. To help prepare participants for preclinical development, speakers will discuss the critical decisions and steps that can be employed for the development of novel potential neurodegenerative disease therapies from the early stages of discovery to preclinical validation studies.
Speakers to include drug discovery specialists from Charles River Laboratories and Dr. Philippe Séguéla of the Neuro (Montreal Neurological Insitute-Hospital).